Gerresheimer cuts 2026 outlook citing project delays, production expansion costs
Financial Performance and Outlook Update
2026 Margin Outlook Reduction
June 29 (Reuters) - German medical packaging firm Gerresheimer cut its margin outlook for 2026, saying project delays and operational issues including production ramp-ups weighed on earnings.
2025 Revenue and Dividend Announcement
In a separate statement, the Duesseldorf-based company said its revenue in the 2025 financial year came at €2.3 billion ($2.62 billion), broadly in line with an LSEG poll of analysts, but it said it will not pay a dividend for the period.
Share Price Reaction
Its shares fell almost 10% following the announcement but recovered some losses and were down 3% by 1053 GMT, after losing almost 15% of their value since the beginning of the year.
Adjusted EBITDA Margin and Cash Flow Expectations
EBITDA Margin Forecast
Gerresheimer now expects an adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) margin of around 17% to 18% for the current year before M&A and refinancing activities, down from a previous forecast of 18% to 19%.
Free Cash Flow Projection
Gerresheimer also anticipates negative free cash flow of between €-50 million and €-100 million.
Exchange Rate Information
($1 = 0.8772 euros)
Reporting Credits
(Reporting by Danny Callaghan and Paolo Laudani in Gdansk; Editing by Susan Fenton)
